Exemestan in breast cancer treatment

Journal Title: OncoReview - Year 2012, Vol 2, Issue 4

Abstract

Hormonotherapy is one of the most important therapeutic options in the breast cancer treatment, either locally advanced or metastatic. Tamoxifen has been standard of care for many years, however new clinical trials results indicates aromatase inhibitors as a valuable alternative for postmenopausal patients. Exemestane is a steroid aromatase inhibitor with effectiveness proven in clinical trials discussed in this article.

Authors and Affiliations

Elżbieta Wójcik

Keywords

Related Articles

Tumor lysis syndrome

Tumor lysis syndrome is a life-threatening oncological emergency occurring in response to chemotherapy or spontaneously as a result of massive and rapid breakdown of malignant cells. The release of their contents into ci...

The quality of life and the sexual activity of prostate cancer patients after radical radiotherapy in comparison with group without cancer

[b]Background:[/b] Prostate cancer is a disease with a significant impact on quality of life (QoL) both during and after cancer treatment.[b]The aim of study[/b]: The aim of this study was assessment of QoL and sexual ac...

Merkel cell carcinoma

Merkel cell carcinoma (MCC) is a rare cutaneous malignancy, with aggressive behaviour. The discovery of MCC polyomavirus (MCPyV) provided a major insight into pathogenesis of MCC, as MCPyV is present in most MCC tumours....

58-year-old woman with pancreatic neuroendocrine tumour

We reported a 58-year-old woman with tumor in the tail and body of pancreas measuring 70 mm in diameter who underwent distal pancreatectomy and splenectomy. Examination of a specimen of the pancreatic mass obtained histo...

Delayed anthracycline-induced cardiomyopathy – case report

43-year-old man was admitted to the hematology department due to second recurrence of anaplastic lymphoma T-cell ALK+. Lymphoma was diagnosed 28 years earlier. The patient received COP regimen (17 cycles) and CHOP (5 cyc...

Download PDF file
  • EP ID EP53184
  • DOI -
  • Views 217
  • Downloads 0

How To Cite

Elżbieta Wójcik (2012). Exemestan in breast cancer treatment. OncoReview, 2(4), -. https://europub.co.uk/articles/-A-53184